A Phase 1 study of OPL-0401 in healthy volunteers and individuals with renal insufficiency
Latest Information Update: 22 Aug 2022
At a glance
- Drugs OPL-0401 (Primary)
- Indications Diabetic complications; Diabetic retinopathy; Renal failure
- Focus Adverse reactions
- Sponsors Valo Health
Most Recent Events
- 22 Aug 2022 New trial record